/ Not yet recruitingNot Applicable Yoga-based, Movement Therapy Device as Noninvasive Glymphatic Clearance Augmentation in Alzheimer's Disease.
The Feasibility and Safety Trial With Preliminary Clinical, Digital, and Fluid Biomarker Proxies of Glymphatic Clearance
This clinical trial evaluates a yoga-based intervention delivered through a powered therapeutic device designed to guide breathing and body movements. Building on evidence that mind-body practices may promote healthy aging, cognitive function, and glymphatic flow, the study uses physiological measurements, including fNIRS and wearable sensors, to investigate mechanisms and potential benefits in individuals at risk for Alzheimer's disease.
100 Clinical Results associated with Ciatrix, Inc.
0 Patents (Medical) associated with Ciatrix, Inc.
100 Deals associated with Ciatrix, Inc.
100 Translational Medicine associated with Ciatrix, Inc.